We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Patent term extensions for biologic innovators in Japan.
- Authors
Tessensohn, John A.; Yamamoto, Shusaku
- Abstract
The article considers the benefit of the decisions by the Intellectual Property High Court of Japan upholding the market exclusivity period for the brand biologic Enbrel (etanercept) to the biotechnology industry in 2011. The establishment of the Japanese patent term extension (PTE) and accelerated patent examination legislative regimes are also discussed. An overview of the state of biosimilars market in Japan is given. It presents information on the mechanism of action of etanercept.
- Subjects
JAPAN; PATENTS; INTELLECTUAL property; ETANERCEPT; BIOTECHNOLOGY industries
- Publication
Nature Biotechnology, 2011, Vol 29, Issue 1, p34
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt.1743